Why is Senores Pharma. falling/rising?

As of 29-Jul, Senores Pharmaceuticals Ltd is experiencing a significant rise in its stock price, currently at 703.95, reflecting an increase of 61.0 or 9.49%. The stock has recently hit a new 52-week and all-time high of Rs. 715.8, indicating strong upward momentum. Over the past week, the stock has outperformed the sector by 8.08% and has shown a notable return of 23.96% over the past month, while the benchmark Sensex has declined by 3.24% during the same period. Despite a recent trend reversal after two days of consecutive decline, the stock is trading above its moving averages, suggesting a bullish trend. However, there has been a slight decrease in investor participation, with delivery volume falling by 3.02% against the five-day average, which could indicate some caution among investors.
In the broader market context, Senores Pharmaceuticals' strong short-term performance contrasts sharply with the Sensex, which has seen a decline of 1.03% over the past week. The company benefits from a low debt-to-equity ratio and impressive growth metrics, with net sales increasing at an annual rate of 85.60% and operating profit at 130.72%. However, the stock's valuation appears expensive with a price-to-book value of 4.1, and there has been a decrease in institutional investor participation, which may raise concerns about future price stability. Overall, while the stock is currently rising due to strong performance metrics and recent positive results, the decline in institutional interest and high valuation could pose risks moving forward.